Finished
Chinese Surgical Robot Clinical Study on Rectectomy for Rectal Cancer
NCT04836741 · The Third Xiangya Hospital of Central South University · Updated 8 April 2021
- What is being tested
- Micro Hand S robot; Laparoscope
- For
- Rectal Cancer
- Kind of study
- Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
- Who can join
- Ages 18 years to 80 years. About 105 people. The full rules are on the registry page.
- Where
- China
- When
- Starts or started 1 July 2015, ends 31 Dec 2019. Registered 8 April 2021.
- Results
- None posted yet.
In the researchers' words
Central South University in collaboration with Tianjin University developed the first domestically produced Chinese minimally invasive surgical (MIS) robot system which named "Micro Hand S" in 2013. This new MIS robot had been authorized to enter the clinical trial stage by the Ethics Committee of the Third Xiangya Hospital at Central South University. The Micro Hand S robot is safe and feasible in the preliminary study. However, compared with minimally invasive approaches (da Vici, laparoscope), the merits and demrits of rectectomy for rectal cancer are unclear. Therefore, the investigators conduct this retrospective study to focus on this concern.
Sites
- The Third Xiangya Hospital of Central South UniversityChangsha, Hunan, China